• Profile
Close

One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis

Nephrology Dialysis Transplantation Nov 17, 2017

Floege J, et al. - The efficacy, as well as tolerability of sucroferric oxyhydroxide and sevelamer in the peritoneal dialysis (PD) patient population, were investigated in this subanalysis. In this patient population, sucroferric oxyhydroxide afforded a relatively low pill burden and a high rate of adherence but was noninferior to sevelamer for controlling serum phosphorus.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay